Yue Hui Su
Directeur/Membre du Conseil chez MAKALOT INDUSTRIAL CO., LTD.
Postes actifs de Yue Hui Su
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MAKALOT INDUSTRIAL CO., LTD. | Directeur/Membre du Conseil | 21/02/2011 | - |
| Independent Dir/Board Member | - | - | |
| IN WIN DEVELOPMENT INC. | Directeur/Membre du Conseil | 01/07/2015 | - |
| Independent Dir/Board Member | 01/07/2015 | - | |
| ENNOCONN CORPORATION | Directeur/Membre du Conseil | - | - |
| Independent Dir/Board Member | - | - | |
| FORMOSA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 09/07/2021 | - |
| Independent Dir/Board Member | 09/07/2021 | - | |
| CECI Engineering Consultants, Inc. | Directeur/Membre du Conseil | - | - |
| Soochow University /Taiwan/ | Corporate Officer/Principal | - | - |
Historique de carrière de Yue Hui Su
Anciens postes connus de Yue Hui Su
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TWI PHARMACEUTICALS INC | Directeur/Membre du Conseil | - | - |
| Independent Dir/Board Member | - | - | |
| Soochow University | Corporate Officer/Principal | - | - |
| BANK OF KAOHSIUNG CO., LTD. | Directeur/Membre du Conseil | 20/06/2002 | - |
Formation de Yue Hui Su
| National Taiwan University | Doctorate Degree |
Statistiques
Internationale
| Taïwan | 10 |
| Chine | 2 |
Opérationnelle
| Director/Board Member | 7 |
| Independent Dir/Board Member | 5 |
| Corporate Officer/Principal | 2 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 3 |
| Electronic Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| MAKALOT INDUSTRIAL CO., LTD. | Consumer Non-Durables |
| BANK OF KAOHSIUNG CO., LTD. | Finance |
| IN WIN DEVELOPMENT INC. | Electronic Technology |
| ENNOCONN CORPORATION | Electronic Technology |
| FORMOSA PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
| CECI Engineering Consultants, Inc. | |
TWi Pharmaceuticals, Inc.
 TWi Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TWi Pharmaceuticals, Inc. operates as a technology-based special pharmaceutical company. The firm engages in the development and commercialization of high barrier generics drugs. Its products include donepezil hydrochloride tablets, megestrol acetate oral suspension, hydroquinone cream, guanfacine extended-release tablets and nifedipine extended-release tablets. The company was founded by Chih Ming Chen on December 1, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
- Bourse
- Insiders
- Yue Hui Su
- Expérience
